Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.

Literature DB >> 6454384

In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.

Abstract

The in vitro activities of four new beta-lactam antibiotics and dibekacin against aerobic bacteria were compared. The new cephalosporins were more broadly active against gram-negative bacteria than were presently available cephalosporins, but were less active against staphylococci.

Entities: Chemical

Mesh：

Substances：

Year: 1981 PMID： 6454384 PMCID： PMC181459 DOI： 10.1128/AAC.19.3.490

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

5 in total

1. Comparative evaluation of piperacillin in vitro.

Authors: G M Dickinson; T J Cleary; T A Hoffman
Journal: Antimicrob Agents Chemother Date: 1978-12 Impact factor: 5.191

2. In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa.

Authors: A G Paradelis; J Douboyas; G Stathopoulos; A Grigoriadou-Edipides; C Triantaphylidis; J Papapanagiotou
Journal: Antimicrob Agents Chemother Date: 1978-09 Impact factor: 5.191

3. In vitro evaluation of cefoperazone.

Authors: A M Hinkle; B M LeBlanc; G P Bodey
Journal: Antimicrob Agents Chemother Date: 1980-03 Impact factor: 5.191

4. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.

Authors: L G Reimer; S Mirrett; L B Reller
Journal: Antimicrob Agents Chemother Date: 1980-03 Impact factor: 5.191

5. LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.

Authors: R Wise; J M Andrews; K A Bedford
Journal: Antimicrob Agents Chemother Date: 1979-09 Impact factor: 5.191

5 in total

4 in total

In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.

1. Comparative evaluation of piperacillin in vitro.

2. In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa.

3. In vitro evaluation of cefoperazone.

4. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.

5. LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.

1. Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma.

2. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.

3. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].

Review 4. Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.